Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Irinotecan in Pediatric Solid Tumors
NCT02747537Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sorafenib in solid tumor, sponsored by Washington University School of Medicine. Planned start Jun 2016; status: withdrawn.
02
Drugs
sorafenib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02747537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02747537.